Magali is an expert consultant in CMC and drug development, offering over 21 years of experience in neuropsychiatry, metabolic disorders, and oncology. Her expertise spans preclinical research to commercial launch, focusing on drug delivery, formulation, and process development. She has led teams to advance various dosage forms and collaborated on high-profile brands like Aristada® and Vumerity®. Magali holds a PhD in Organic Chemistry from Brandeis University and has published extensively in peer-reviewed journals. Outside of work, she enjoys cooking, gardening, writing, and donating woodworking projects to charitable organizations.